ID

21083

Description

A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00448591

Lien

https://clinicaltrials.gov/show/NCT00448591

Mots-clés

Versions (1)
  1. 09/04/2017 09/04/2017 -
Téléchargé le

9 avril 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer DRKS00003642 NCT00448591

Anglais

Eligibility Breast Cancer NCT00448591

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients, >=18 years of age;
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
her-2 negative adenocarcinoma of the breast, with locally recurrent or metastatic disease; (her-2 positive patients only if previously treated with herceptin in the adjuvant setting;
Description

adenocarcinoma of the breast, her-2 negative, locally recurrent or metastatic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C3853888
UMLS CUI [1,3]
C0338204
UMLS CUI [2]
C0861355
UMLS CUI [3]
C1697918
candidates for chemotherapy.
Description

chemotherapy candidate

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332149
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous chemotherapy for metastatic or locally recurrent breast cancer;
Description

previous chemotherapy for metastatic or locally recurrent breast cancer

Type de données

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C1697918
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C0205156
concomitant hormonal therapy for metastatic or locally recurrent disease;
Description

concomitant hormonal therapy for metastatic or locally recurrent breast cancer

Type de données

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C0279025
UMLS CUI [1,3]
C0521115
UMLS CUI [2,1]
C1697918
UMLS CUI [2,2]
C0279025
UMLS CUI [2,3]
C0521115
concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive disease;
Description

concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive breast cancer

Type de données

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C3853888
UMLS CUI [1,3]
C0338204
UMLS CUI [1,4]
C0521115
UMLS CUI [2,1]
C1697918
UMLS CUI [2,2]
C3853888
UMLS CUI [2,3]
C0338204
UMLS CUI [2,4]
C0521115
previous radiotherapy for treatment of metastatic disease;
Description

previous radiotherapy of metastatic breast cancer

Type de données

boolean

Alias
UMLS CUI [1,1]
C1697918
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C0205156
evidence of cns metastases.
Description

breast cancer with cns metastases

Type de données

boolean

Alias
UMLS CUI [1,1]
C1697918
UMLS CUI [1,2]
C0686377
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT00448591

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
patients, >=18 years of age;
boolean
C0001779 (UMLS CUI [1])
adenocarcinoma of the breast, her-2 negative, locally recurrent or metastatic
Item
her-2 negative adenocarcinoma of the breast, with locally recurrent or metastatic disease; (her-2 positive patients only if previously treated with herceptin in the adjuvant setting;
boolean
C0858252 (UMLS CUI [1,1])
C3853888 (UMLS CUI [1,2])
C0338204 (UMLS CUI [1,3])
C0861355 (UMLS CUI [2])
C1697918 (UMLS CUI [3])
chemotherapy candidate
Item
candidates for chemotherapy.
boolean
C0392920 (UMLS CUI [1,1])
C0332149 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
previous chemotherapy for metastatic or locally recurrent breast cancer
Item
previous chemotherapy for metastatic or locally recurrent breast cancer;
boolean
C0278493 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C1697918 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
concomitant hormonal therapy for metastatic or locally recurrent breast cancer
Item
concomitant hormonal therapy for metastatic or locally recurrent disease;
boolean
C0278493 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0521115 (UMLS CUI [1,3])
C1697918 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
C0521115 (UMLS CUI [2,3])
concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive breast cancer
Item
concomitant herceptin therapy for treatment of metastatic or locally recurrent her-2 positive disease;
boolean
C0278493 (UMLS CUI [1,1])
C3853888 (UMLS CUI [1,2])
C0338204 (UMLS CUI [1,3])
C0521115 (UMLS CUI [1,4])
C1697918 (UMLS CUI [2,1])
C3853888 (UMLS CUI [2,2])
C0338204 (UMLS CUI [2,3])
C0521115 (UMLS CUI [2,4])
previous radiotherapy of metastatic breast cancer
Item
previous radiotherapy for treatment of metastatic disease;
boolean
C1697918 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
breast cancer with cns metastases
Item
evidence of cns metastases.
boolean
C1697918 (UMLS CUI [1,1])
C0686377 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial